Interpretation of 2002 Centers for Disease Control Guidelines for Group B Streptococcus and Evolving Provider Practice Patterns

ABSTRACT

We investigated if clinicians were altering their care of group B streptococcus (GBS)-positive women in labor to achieve 4 hours of intrapartum antibiotic prophylaxis based on their interpretation of the 2002 Centers for Disease Control (CDC) guidelines on prevention of perinatal GBS disease. We surveyed all clinicians with privileges on the labor floor at our institution about their interpretation and clinical application of the 2002 CDC guidelines. Seventy of 96 eligible clinicians (72.9%) completed our survey. In our survey, only 22.9% of clinicians reported not altering their management of labor in GBS-positive pregnancies that achieved less than 4 hours of prophylaxis. These alterations included “laboring down” or delaying pushing; turning off or decrease an oxytocin infusion; or delaying or avoiding artificial rupture of membranes. Clinicians are altering their management of labor to attempt to achieve 4 hours of intrapartum prophylaxis. The 2002 CDC guidelines do not specifically recommend prolonging labor and are being interpreted differently in the clinical setting than the authors may have intended. The effects and consequences of this interpretation are unknown.

KEYWORDS

Group B streptococcus - intrapartum prophylaxis - CDC guidelines - early onset neonatal sepsis

REFERENCES

• 1 Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms.  Clin Microbiol Rev. 1998;  11 497-513
• 2 Centers for Disease Control and Prevention (CDC) . Early-onset and late-onset neonatal group B streptococcal disease—United States, 1996–2004.  MMWR Morb Mortal Wkly Rep. 2005;  54 1205-1208
• 3 Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.  MMWR Recomm Rep. 2002;  51 (RR-11) 1-22
• 4 Illuzzi J L, Bracken M B. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review.  Obstet Gynecol. 2006;  108 1254-1265
• 5 Davis R L, Hasselquist M B, Cardenas V et al.. Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization.  Am J Obstet Gynecol. 2001;  184 603-610
• 6 Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.  MMWR Recomm Rep. 1996;  45 (RR-7) 1-24
• 7 Boyer K M, Gadzala C A, Kelly P D, Gotoff S P. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission.  J Infect Dis. 1983;  148 810-816
• 8 de Cueto M, Sanchez M J, Sampedro A, Miranda J A, Herruzo A J, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus.  Obstet Gynecol. 1998;  91 112-114
• 9 Lin F Y, Brenner R A, Johnson Y R et al.. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.  Am J Obstet Gynecol. 2001;  184 1204-1210
• 10 Pylipow M, Gaddis M, Kinney J S. Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns.  Pediatrics. 1994;  93 631-635
• 11 Schrag S J, Zell E R, Lynfield R Active Bacterial Core Surveillance Team et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.  N Engl J Med. 2002;  347 233-239
• 12 McNanley A R, Glantz J C, Hardy D J, Vicino D. The effect of intrapartum penicillin on vaginal group B streptococcus colony counts.  Am J Obstet Gynecol. 2007;  197 583 e1-4
• 13 Barber E L, Zhao G, Buhimschi I A, Illuzzi J L. Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery.  Obstet Gynecol. 2008;  112 (2 Pt 1) 265-270